Name Net increased
positions
Increased positions Reduced positions Return since
30 Sep ‘17
101
9 14 5 7.55%
102
9 19 10 25.1%
103
9 14 5 25.1%
PDSB icon
104
PDS Biotechnology
PDSB
$68.1M
9 23 14 99.4%
105
9 55 46 88.6%
106
9 15 6 52.3%
107
9 34 25 96.2%
108
9 13 4 45.7%
109
9 37 28 61.3%
110
9 12 3 50.9%
OSG
111
Octave Specialty Group
OSG
$204M
9 44 35 73.7%
112
9 128 119 100%
113
9 47 38 94.2%
114
8 28 20 71.9%
115
8 20 12 6.46%
116
8 27 19 4.16%
117
8 20 12 41.1%
118
8 16 8 47.9%
119
8 9 1 124%
120
8 41 33 90.4%
121
8 24 16 70.6%
122
8 24 16 83%
123
8 45 37 73.3%
124
8 17 9 39.5%
125
8 46 38 85.6%